Neonatal size unaffected by gestational diabetes drugs

Neonatal size unaffected by gestational diabetes drugs
Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

(HealthDay)—Women with gestational diabetes mellitus treated with metformin or insulin have similar changes in markers of metabolic status and no differences in offspring birth weight, according to a study published in the March issue of Diabetes Care.

Helen L. Barrett, M.B.B.S., from the University of Queensland in Herston, Australia, and colleagues examined the association between circulating maternal and neonatal markers of metabolic status (glucose, lipids, C-reactive protein) with infant size at birth in women with gestational diabetes mellitus, where 236 women had been randomly assigned to metformin and 242 had been randomly assigned to insulin.

The researchers found that women treated with metformin had a significantly greater increase in triglycerides at 36 weeks of gestation (21.93 versus 9.69 percent). There were no other differences between treatment groups for maternal or neonatal metabolic markers or neonatal anthropometry. After adjusting for possible confounding variables, including maternal , a birth weight in the >90th percentile was associated with markers of , maternal , and triglycerides, while a birth weight in the <10th percentile was associated with triglycerides.

"There were few differences in circulating maternal and neonatal markers of metabolic status and no differences in measures of anthropometry between the offspring of women treated with metformin and the offspring of women treated with insulin," Barrett and colleagues conclude.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Gestational diabetes, obesity impact pregnancy outcomes

Mar 02, 2012

(HealthDay) -- Women with gestational diabetes mellitus (GDM) who are obese have significantly higher odds of adverse pregnancy outcomes, according to findings from the multinational Hyperglycemia and Adverse ...

Recommended for you

Scientist finds clearer obesity, diabetes connection

Aug 27, 2014

(Medical Xpress)—New findings about the biological links between obesity and insulin resistance and Type 2 diabetes may also shed light on the connection between obesity and cancer, says a scientist at ...

New test helps diagnose type 1 diabetes

Aug 21, 2014

(HealthDay)—The U.S. Food and Drug Administration has approved a new test that may help doctors diagnose type 1 diabetes, the most common form diagnosed in children and adolescents.

User comments